| Serial Number | 87528232 |
| Word Mark | CREATIVE ENZYMES |
| Filing Date | Friday, July 14, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, August 30, 2024 |
| Registration Number | 5406516 |
| Registration Date | Tuesday, February 20, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 5, 2017 |
| Description of Mark | The mark consists of four chevron shaped molecular structures arranged in a circle with the points of each chevron facing the center with the leftmost one in orange, the top one in dark blue, the rightmost one in green, and the bottom one in light blue, and the words "CREATIVE ENZYMES" in dark blue on the right side of the design. |
| Indication of Colors claimed | The color(s) orange, blue, and green is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "ENZYMES" |
| Goods and Services | Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineering |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, January 1, 2013 |
| First Use In Commerce Date | Tuesday, January 1, 2013 |
| Party Name | Creative BioMart, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Party Name | Creative BioMart, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Party Name | Creative BioMart, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Event Date | Event Description |
| Thursday, July 20, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 13, 2017 | ASSIGNED TO EXAMINER |
| Friday, October 13, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 13, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 13, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 13, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, October 30, 2017 | ASSIGNED TO LIE |
| Wednesday, November 15, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 5, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 5, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 20, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, February 20, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, August 30, 2024 | CANCELLED SEC. 8 (6-YR) |
| Monday, October 8, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 18, 2017 | NEW APPLICATION ENTERED |
| Friday, July 21, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, October 13, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |